Orasis Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ORASIS PHARMS, and what generic alternatives to ORASIS PHARMS drugs are available?
ORASIS PHARMS has one approved drug.
There are four US patents protecting ORASIS PHARMS drugs.
There are twenty-two patent family members on ORASIS PHARMS drugs in fourteen countries.
Drugs and US Patents for Orasis Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Orasis Pharms | QLOSI | pilocarpine hydrochloride | SOLUTION;OPHTHALMIC | 217836-001 | Oct 17, 2023 | RX | Yes | Yes | 9,867,810 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
Orasis Pharms | QLOSI | pilocarpine hydrochloride | SOLUTION;OPHTHALMIC | 217836-001 | Oct 17, 2023 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
Orasis Pharms | QLOSI | pilocarpine hydrochloride | SOLUTION;OPHTHALMIC | 217836-001 | Oct 17, 2023 | RX | Yes | Yes | 11,129,812 | ⤷ Subscribe | ⤷ Subscribe | ||||
Orasis Pharms | QLOSI | pilocarpine hydrochloride | SOLUTION;OPHTHALMIC | 217836-001 | Oct 17, 2023 | RX | Yes | Yes | 11,974,986 | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Orasis Pharms Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Brazil | 112019002967 | ⤷ Subscribe |
South Korea | 102588499 | ⤷ Subscribe |
Israel | 264664 | ⤷ Subscribe |
Poland | 3500255 | ⤷ Subscribe |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.